Jan 5, 2022 | Stevenage Bioscience Catalyst
An independent report has been released by Stevenage Bioscience Catalyst (SBC) that demonstrates its key role in delivering economic benefit from life sciences research and innovation in the UK. SBC was formed in 2012 through a collaboration between the Department for...
Nov 18, 2021 | Member News, Stevenage Bioscience Catalyst
Pictured left to right: Dr Hugo Villanueva (SBC), Dr Ajay Mistry (founder and CEO of Oppilotech Ltd) and Dr Sally Ann Forsyth OBE (CEO of SBC) 15 start-ups with huge potential have successfully completed the Data-driven Advanced Therapeutics Accelerator (DATA)...
Jul 16, 2021 | GSK, Member News, Sector News, Stevenage Bioscience Catalyst
GSK has announced that it has formally started the process of seeking a development partner to transform land within the company’s existing 92-acre Research & Development site in Stevenage into one of Europe’s largest ‘clusters’ for biotechnology and other...
Feb 24, 2021 | Stevenage Bioscience Catalyst
Stevenage Bioscience Catalyst (SBC) has launched a free accelerator programme to give data-focussed biotech start-ups the skills they need to get potential new drugs and therapies to market more quickly. The programme will run from May and is aimed at supporting...
Jan 4, 2021 | Member News, Stevenage Bioscience Catalyst
Dr Sally Ann Forsyth, CEO of Stevenage Bioscience Catalyst (SBC), thanks her colleagues and collaborators after being honoured in the 2021 New Year Honours list. Sally Ann has been awarded an Officer of the Order of the British Empire (OBE) for services to business...
Nov 24, 2020 | Member News, Stevenage Bioscience Catalyst
Stevenage Bioscience Catalyst (SBC), a leading location for development and commercialisation of cutting-edge therapeutics, is pleased to announce the opening of the Lab Hotel, a lab and office facility for early-stage start-ups in the field of advanced therapeutics...
